title: Mini test dose of intravenous busulfan (busulfex(®)) in allogeneic non-myeloablative stem cell transplantation, followed by liquid chromatography tandem-mass spectrometry.
authors.affiliation: Department of Medicine, Division of Oncology, Duke University Medical Center, Durham, NC, USA. ivan.spasojevic@dm.duke.edu
authors.forename: Ivan
authors.initials: I
authors.lastname: Spasojevic
authors.forename: Ligia R S
authors.initials: LR
authors.lastname: da Costa
authors.forename: Mitchell E
authors.initials: ME
authors.lastname: Horwitz
authors.forename: Gwynn D
authors.initials: GD
authors.lastname: Long
authors.forename: Keith M
authors.initials: KM
authors.lastname: Sullivan
authors.forename: John P
authors.initials: JP
authors.lastname: Chute
authors.forename: Cristina
authors.initials: C
authors.lastname: Gasparetto
authors.forename: Ashley
authors.initials: A
authors.lastname: Morris
authors.forename: Nelson J
authors.initials: NJ
authors.lastname: Chao
authors.forename: David A
authors.initials: DA
authors.lastname: Rizzieri
mesh_terms: D002066:Busulfan / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D002853:Chromatography, Liquid; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D053719:Tandem Mass Spectrometry; D013810:Therapeutic Equivalency; D019172:Transplantation Conditioning
chemical_list: D002066:Busulfan